Reference Identification

Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire

Annals of Rheumatic Diseases, Joanna Robson, Jill Dawson, Helen Doll, Peter F Cronholm, Nataliya Milman, Katherine Kellom, Susan Ashdown, Ebony Easley, Don Gebhart, Georgia Lanier, John Mills, Jacqueline peck, Raashid Ahmed Luqmani, Judy Shea, Gunnar tomasson, Peter Merkel dis 2018; 77:1157-64
Country: UK, USA and Canada
Language: English
https://www.ncbi.nlm.nih.gov/pubmed/29695498

Other references of interest

https://www.ncbi.nlm.nih.gov/pubmed/29379322

Robson JC, et al. Health-related quality of life in ANCA-associated vasculitis and item generation for a disease specific patient-reported outcome measure. Patient Relat Outcome Meas. 2018;9:17-34

Overall description of the ‘Stage 1’ of the development of the new disease specific AAV-PRO instrument measuring HRQoL in patients with AAV: item generation and piloting.

https://www.ncbi.nlm.nih.gov/pubmed/28864650

Robson JC, et al. OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis. J Rheumatol 2017;44(10):1529-1535

Report of the approval process by OMERACT for the use of the generic PROMIS instruments (for fatigue, physical functioning, and pain interference) and the AAV-PRO (disease-specific PRO for AAV) in clinical trials of AAV. The instruments were assessed and endorsed by using a novel 5-step assessment tool, the OMERACT Filter 2.0 Instrument Selection Algorithm (OFISA) and red-amber-green checklist (also known as the “eyeball test”).

Instrument/Tool Translations References

---